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Abstract 
Background: To study the clinico- haematological 
profile of  lipid storage disorders in pediatric age group on 
bone marrow examination.  
Methods: In this descriptive study, clinico-
haematological profile of patients with lipid storage 
diseases in 1147 patients who underwent bone marrow 
examination, was studied.  
Results: A total number of 20 cases of lipid storage 
disease were diagnosed. The mean age was 2 yrs. 
Thirteen(69%)  were male , with a male to female ratio of 
2.2:1. Ten (50%) cases presented with severe symptoms. 
Hepatosplenomegaly was present in majority(75%). 
Failure to thrive was the commonest clinical presentation. 
Pancytopenia was seen in 80%. 
Conclusion: Niemann-Pick  disease 65%) was the 
commonest, followed by Gaucher’s Disease (35%).  
Key Words: Gaucher’s Disease; Lipid Storage 
disorders; Niemann-Pick Disease.  
 
Introduction 
    The term storage diseases is used for certain 
metabolic disorders which cause accumulation of 
incompletely catabolised tissue products in the 
monocyte macrophage systems. The fundamental 
defect in all of these lipidoses is the accumulation of 
ceramide compounds in various cells and tissues. 
Gaucher’s and  Niemann – Pick disease are autosomal 
recessive and Fabry’s disease is an X-linked storage 
disease . Gaucher’s disease is found in greater 
frequency  in eastern and central European Ashkenazi 
Jews.  These disorders are also called familial 
sphingolipidoses, since inherited deficiency of certain 
enzymes (glucoceribrosidase in Gaucher’s disease and 
sphingomylinase in Niemann Pick disease) required 
for the catabolism of lipid compounds leads to the 
accumulation of these lipids and polysaccharides. The 
stockpiled substance is mainly accumulated in the 
macrophages. Accumulation of these lipid- laden 
macrophages in the blood, bone marrow, spleen, liver 
and other organs leads  to manifestations like 
anaemia, leucopenia, thrombocytopenia and hepato-
splenomegaly. 1-4  . 
     Gaucher’s  disease is characterized by a variety of 
phenotypes. The severity is extremely variable, with 
some patients presenting in childhood with virtually 
all the complications, while others remain 
asymptomatic and may present late. Gaucher disease 
is divided into three clinical subtypes, on the basis of 
neurologic involvement and its progression, e.g. type 
1 - non-neuromyopathic form,type 2 - acute 
neuromyopathic form and type 3 -  the chronic 
neuromyopathic form. Some patients, however defy 
classification.5-7 
    Niemann-Pick disease refers to a group of diseases 
passed down through families in which lipids collect 
in the reticuloendothelial cells of the spleen, liver, and 
brain .There are four most commonly recognized 
forms of the disease, i.e., types A, B, C, and D. Types 
A and B are also called Type I. Types C and D are also 
known as Type II.Both the types may involve different 
organs with or without central nervous system or 
respiratory involvement. Each type has different 
symptoms and may occur at different times 
throughout life, from infancy to adulthood.8 
 
Patients and Methods 
    This study was performed from January  2005 to 
Sep 2010, in department  of Pathology, Army Medical 
College and Military Hospital, Rawalpindi.During this 
period a total of 1147 patients underwent bone 
marrow aspiration for different indications in the Dept 
of Pathology MH/ AM College Rawalpindi. Bone 
marrow aspiration was done in the conventional way 
but with a 16 G spinal needle. The site of aspiration 
was posterior iliac spine in adults and tibial tuberosity 
in children up to two years.The slides were stained 
with Leishman stain Perl’s Prussian blue reaction was 
used to stain iron. Special stain, ACP, was used to 
distinguish between the Gaucher and the Niemann- 
Pick cell morphology.  
  
Results 
    A total number of 20 cases of lipid storage disease 
were diagnosed. Out of these 13 were Niemann-Pick 
while 7 were Gaucher’s disease  
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Table 1: Lipid storage diseases – Clinico-
haematological profile 
Characteristic No(%) 
Type 
  -Niemann- Pick Disease 
  - Gaucher’s Disease  
 
13(65) 
7(35) 
Failure to thrive 20(100) 
Anaemia 20(100) 
Pancytopenia 16(80) 
Hepatosplenomegaly 20(100) 
 
Table 2: Severity of Disease 
Severity of disease No(%) 
Mild  5 (25) 
Moderate 5(25) 
Severe  10(50) 
Mild: Fever with cytopenias; Moderate: Above symptoms 
with organomegaly; Severe: Both of the above plus 
neurological defecit 
 
 
Fig.1. Bone marrow aspirate showing a 
Niemann-Pick cell. Monocytes with foamy 
appearance of cytoplasm due to lipid vacuoles  
 
     The mean age was 2 yrs. 13 males(69%) and 7 
females(31%) were affected. The male to female ratio 
was 2.2:1. Ten(50%) cases presented with severe 
symptoms while clinically hepatosplenomegaly was 
present in 15(75%) cases. Blood complete picture 
showed anaemia in all(Table 1). Nine  patients of 
Niemann Pick disease had severe symptoms while 
only one patient with Gaucher’s disease had severe 
symptoms (Table 2). Almost all of these patients had 
failure to thrive and delayed milestones or 
deteriorating neurological signs. On bone marrow 
examination foamy accumulations were evident in 
Niemann –Pick, while fibriller cytoplasm was 
characteristic in Gaucher’s disease (Fig 1 &2) 
 
Fig.2. Bone marrow aspirate showing Gaucher cells. 
Monocytes with pale blue cytoplasm and round to oval 
nuclei. Cytoplasm  appear fibriller and wrinkled  
 
Discussion 
     Storage disorders are uncommon amongst our 
population. Being a genetic disorder with high 
mortality rate, parents hesitate to bring forth these 
patients to hospital for treatment. Consequently the 
obvious outcome in our community is fatal. In present 
study 13 out of the 20 cases were of Niemann-Pick 
disease, while international studies reveal a higher 
incidence of Gauchers disease. 9  Local data recorded 
variable results. A study from Islamabad correlated 
with present study. 1,2   
     The true prevalence is difficult to assess because of 
the lack of awareness about these disorders and 
difficulty in the biochemical testing. Other reason 
could be that either the patients die before reporting to 
the hospital or the parents have already had children 
with the same disorder and they are aware of the fatal 
outcome so they hesitate to bring forth these patients 
as they are non affording and have social constraints. 
     The mean age was 22 months. Probably these 
disorders are so severe that these patients don’t reach 
the second decade of their life. Another reason is the 
lack of treatment options, the treatment being very 
expensive and lifelong. Although internationally 
patients are given Enzyme Replacement Therapy and 
they do cross the second decade of their lives.6,7 
     The only diagnostic modality available in our 
country is bone marrow examination. In this study, all 
the diagnoses were made on basis of typical 
morphology of the storage cells in the bone marrow, 
which was augmented by PAS (Periodic Acid 
Schiff)and ACP(Acid Phosphatase) stains. At times, 
patients have to be subjected to bone  marrow 
trephine and splenic puncture. At times we had to 
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subject the patients to trephine biopsy as well. 
Possibility of an enzyme biomarker, to make 
diagnosis, can not be ruled out. 10-12 
     Generally, the treatment is supportive. Enzyme 
replacement therapy (Algiucerase; Imiglucerase) is 
available for Gaucher’s disease, but is expensive. 
These patients are candidates for gene therapy. Bone 
marrow transplantation is the only curative option. 
 
Conclusion 
Detection of specific enzyme deficiency and genetic 
analysis can unearth more cases of lipid storage 
disorders   
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